Renal denervation after Symplicity HTN-3: an update (Q34006930)

30 July 2017

3 references

13 March 2019

17 June 2019

19 September 2019

Renal denervation after Symplicity HTN-3: an update (English)

1 reference

biomedical investigative technique

30 July 2017

arterial hypertension

3 references

13 March 2019

17 June 2019

19 September 2019

4 references

13 March 2019

17 June 2019

19 September 2019

29 May 2020

1 reference

19 September 2019

6

Sverre Kjeldsen

1 reference

30 July 2017

Alexandre Persu

1

1 reference

30 July 2017

Yu Jin

2

1 reference

30 July 2017

Fadl Elmula Mohamed Fadl Elmula

3

1 reference

30 July 2017

Lotte Jacobs

4

1 reference

30 July 2017

Jean Renkin

5

1 reference

30 July 2017

1 August 2014

5 references

Current Hypertension Reports

30 July 2017

13 March 2019

17 June 2019

19 September 2019

29 May 2020

4 references

30 July 2017

13 March 2019

17 June 2019

19 September 2019

16

1 reference

30 July 2017

8

1 reference

30 July 2017

460

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-014-0460-x

30 July 2017

0 references

cites work

Hyperresponders vs. nonresponder patients after renal denervation: do they differ?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

A controlled trial of renal denervation for resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal denervation for hypertension: observations and predictions of a founder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Interventional hypertension: a new hope or a new hype? The need to redefine resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Blood pressure changes after renal denervation at 10 European expert centers.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Accuracy of multi-detector computed tomographic angiography assisted by post-processing software for diagnosis atheromatous renal artery stenosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Munchausen syndrome: a novel cause of drug-resistant hypertension.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal denervation: ultima ratio or standard in treatment-resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal denervation in moderate to severe CKD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

ESH position paper: renal denervation - an interventional therapy of resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

A systematic review of the associations between dose regimens and medication compliance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Eligibility for renal denervation: experience at 11 European expert centers

5 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Residual effect of renal denervation in patients with truly resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Renal denervation for hypertension refractory to renal artery stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Renal artery stenosis after renal sympathetic denervation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Bilateral renal artery stenosis after renal denervation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Severe bilateral renal artery stenosis after transluminal radiofrequency ablation of renal sympathetic nerve plexus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Progression of renal artery stenosis after renal denervation. Impact on 24-hour blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Effect of telmisartan on renal outcomes: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Anatomical eligibility of the renal vasculature for catheter-based renal denervation in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

21 January 2018

Essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Recurrent pulmonary oedema after percutaneous radiofrequency renal denervation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122808

Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension

29 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0460-X

Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients

21 January 2018

1 reference

12 December 2020

Secondary rise in blood pressure after renal denervation

1 reference

12 December 2020

Transcatheter renal sympathetic denervation despite angiographically significant proximal stenosis: proof of concept from a case report

1 reference

12 December 2020

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

1 reference

12 December 2020

Renal denervation for drug-resistant hypertension: suffering its original sin, seeking redemption

1 reference

12 December 2020

Late renal artery stenosis after renal denervation: is it the tip of the iceberg?

1 reference

12 December 2020

Improvement of albuminuria after renal denervation

1 reference

12 December 2020

Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point

1 reference

12 December 2020

Iatrogenic renal artery stenosis after renal sympathetic denervation

1 reference

12 December 2020

Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension

1 reference

12 December 2020

Improved heart rate dynamics in patients undergoing percutaneous renal denervation

1 reference

12 December 2020

Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system

1 reference

12 December 2020

Reflections on renal denervation

1 reference

12 December 2020

A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension

1 reference

12 December 2020

Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension

1 reference

12 December 2020

Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery

1 reference

12 December 2020

Renal nerve denervation--a hypertension bubble?

1 reference

12 December 2020

Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?

1 reference

12 December 2020

Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension

1 reference

12 December 2020

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

1 reference

12 December 2020

Resistant hypertension? Assessment of adherence by toxicological urine analysis

1 reference

12 December 2020

Efficacy and safety of renal denervation in elderly patients with resistant hypertension

1 reference

12 December 2020

Eligibility for percutaneous renal denervation: the importance of a systematic screening

1 reference

12 December 2020

10.1007/S11906-014-0460-X

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference